MedTrace Logo

Laser Etching Effect on Application Mode of Universal Adhesive

NCT04814836 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2021-03-26

No results posted yet for this study

Summary

To evaluate the clinical performance of the restorations by applying the universal adhesive in different modes under the influence of different surface treatments, with Erbium Chromium:Yttrium-Scandium-Gallium-Garnet (Er,Cr:YSGG) laser and acid etching in non-carious cervical lesions.

Conditions

  • Healthy Participant

Interventions

PROCEDURE

Total-etch mode with 35% phosphoric acid (K-ETCHANT) (TE-A group)

35% phosphoric acid was applied to enamel and dentin for 10 s, washed and dried for 5 s. The universal adhesive, Clearfil Universal Bond Quick (CBQ) was applied to enamel and dentin surfaces with a single-use applicator, then gently air-dried for 5 s without waiting, and light-cured for 10 s.

PROCEDURE

Selective-etch mode with 35% phosphoric acid (K-ETCHANT) (SE-A group)

35% phosphoric acid was used only on enamel for 10 s, then washed and dried for 5 seconds. Subsequently, the adhesive was applied in a similar manner to the TE-A group.

PROCEDURE

Total-etch mode with Er, Cr: YSGG laser (Waterlase MD) (TE-L group)

the enamel margin and dentin surfaces of lesions were irradiated with an Er,Cr:YSGG laser (2780 nm, Waterlase MD, BioLase Technology, Inc., San Clemente, CA). Then the adhesive was applied in a similar manner to the TE-A group.

PROCEDURE

Selective-etch mode with Er, Cr: YSGG laser (Waterlase MD) (SE-L group).

The laser system was applied in the same way as described in the TE-L group only on enamel surface. Subsequently, the adhesive was applied in the same way as described in the TE-A group.

PROCEDURE

Self-etch mode Clearfil Universal Bond Quick (Kuraray, Japan) (SE group)

Universal adhesive system (CBQ) was applied to enamel and dentin surfaces without any previous etching. Then gently air-dried for 5 s without waiting, and light-cured for 10 s.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • A. Ruya Yazici · Hacettepe University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-10
Primary Completion
2021-01-10
Completion
2025-03-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04814836 on ClinicalTrials.gov